How Will the Remdesivir Market Grow? Key Trends and Opportunities for 2025 and Beyond
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What key factors are powering the surge in the remdesivir market right now?
In the past few years, the remdesivir market has experienced a significant increase in its size. The market, which is expected to be valued at $6.49 billion in 2024, is projected to surge to $8.52 billion in 2025, displaying a compound annual growth rate (CAGR) of 31.2%. This rise during the historic period is due to factors such as the heightened spread of COVID-19, escalated awareness about remdesivir, governmental backing for remdesivir, as well as clinical experiments and investigations and purchases made by the government.
How fast Is the remdesivir market expected to grow, and what’s its future value?
The market for remdesivir is anticipated to expand significantly in the forthcoming years, reaching a size of $15.91 billion by 2029. This growth is estimated to occur at a compound annual growth rate (CAGR) of 16.9%. The growth drivers during this forecast period are related to the ongoing management of COVID-19, the emergence of new variants, worldwide vaccination drives, readiness for potential pandemics, and global health initiatives. Key trends expected during the forecast period involve personalized healthcare, combination treatments, the ability to scale up production, use of telemedicine and remote patient monitoring, research into new application areas, and the adoption of alternative antiviral treatments.
Get your remdesivir market report here!
https://www.thebusinessresearchcompany.com/sample.aspx?id=3253&type=smp
What are the leading drivers of growth in the remdesivir market?
The anticipation of growth in the remdesivir market is being driven by heightened government expenditures. These expenditures, synonymous with government spending, encompass the total money allotted and dispensed by government or public sector entities to support their operations, initiatives, services, and projects. The growth and accessibility of Remdesivir – a vital antiviral medicine – significantly relies on these expenditures, especially during times of public health emergencies. The accessibility and affordability of Remdesivir can be positively impacted by governmental contributions in the form of funding, regulatory backing, procurement power, and research investments. For example, as stated by the Government Digital Service, a governmental agency in the UK, the central government’s current spending on services saw a rise from $876.47 billion to $963.74 billion in 2022-23. The expenditure on capital projects for services also increased from $81.37 billion in 2021–2022 to $104.72 billion in 2022–2023 USD. Thus, the escalation in government spending is fueling the expansion of the remdesivir market.
What are the key segments defining the remdesivir market?
The remdesivir market covered in this report is segmented –
1) By Route Of Administration: Oral, Intravenous
2) By Dosage Form: Tablets, Frozen Solution, Lyophilized Solution
3) By Distribution Channel: Hospitals, Clinics, Drug Stores/Pharmacies, Online, Other Distribution Channels
Subsegments:
1) By Oral: Tablet Formulation, Liquid Formulation
2) By Intravenous: Ready-To-Use Injectable, Lyophilized Powder For Injection
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3253&type=smp
Who are the key players steering the development of the remdesivir market?
Major companies operating in the remdesivir market include Gilead Sciences Inc., BrightGene Bio-Medical Technology Co Ltd, Hainan Haiyao Co. Ltd., Sichuan Kelun Pharmaceutical Co. Ltd., Hunan Warrant Pharmaceutical, Cipla Limited, Pfizer Inc., Merck & Co. Inc., Cayman Chemical Company, Dr Reddy’s Laboratories Ltd., Inovio Pharmaceuticals, Shenzhen BORUI Pharmaceutical Technology Co. Ltd., Berry Global Group, Hetero Labs Limited, Mylan N.V., Zydus Cadila Health Care Limited, Syngene International Limited, Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Limited, Teva Pharmaceutical Industries, Ferozsons Laboratories Limited, Jubilant Life Sciences, Laurus Labs, Macleods Pharmaceuticals, Natco Pharma, Sandoz Group AG, Strides Pharma Science Limited, Torrent Pharmaceuticals, Beximco Pharmaceuticals Ltd., Fresenius Kabi, Gland Pharma Limited, Hikma Pharmaceuticals, Lark Laboratories
What emerging trends are influencing the growth of the remdesivir market?
One major impediment to market growth is the substantial expense related to the medication. Gilead Sciences, the manufacturer of Remdesivir, has gifted its beginning supply of 1.5 million doses, yet it has indicated that it will need to start pricing the drug for it to be viably produced. There are numerous conjectures surrounding the drug’s price point. The Institute for Clinical and Economic Review (ICER) predicts the cost of Remdesivir to range between $4,580 and $5,080. This steep price of Remdesivir could potentially stall the market’s progression.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3253
Which regions are most influential in expanding the remdesivir market?
North America was the largest region in the remdesivir market in 2024. Middle East is expected to be the fastest growing region in the remdesivir market report during the forecast period. The regions covered in the remdesivir market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
Browse Through More Similar Reports By The Business Research Company:
Cell Culture Consumables And Equipment Global Market Report 2024
Metabolomics Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/metabolomics-global-market-report
Stem Cell Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/stem-cell-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
